TuHURA Biosciences, Inc. HURA
2.10
0.00
0.00%
as of 25 Sep
- Market cap
- $133.8M
- P/E
- 0.0×
Follow HURA
| Dec '25 | Dec '24 | Jun '24 | Dec '23 | Jun '23 | Jun '22 | Jun '21 | Jun '20 | Jun '19 | Jun '18 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
0.78 | 3.68 | 2.45 | 1.16 | 1.06 | 3.32 | 4.24 | 1.07 | 1.94 | 4.30 |
Net Debt/EBITDA |
0.12 | 0.78 | 0.58 | 0.05 | 0.13 | 0.52 | 0.28 | 0.26 | 0.44 | 0.54 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 53.29% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | (1.49) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.92 | 0.65 | 0.84 | 0.41 | 0.79 | 0.81 | 0.45 | 0.87 | 0.78 | 0.87 |
Capex/Depreciation |
(0.14) | (0.04) | (0.36) | (7.11) | (0.07) | 0.00 | (0.04) | 0.00 | 0.00 | (0.51) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (171.92%) | (579.24%) | 210.66% | 510.31% | 281.44% | 983.79% | 933.62% | 242.16% | 406.38% | 2,703.29% | |
| (127.05%) | (173.10%) | (160.95%) | (702.97%) | (150.74%) | (170.43%) | (503.66%) | (262.15%) | (146.30%) | (151.00%) | |
ROIC |
(114.79%) | (569.54%) | 0.00% | 0.00% | 0.00% | (94,508.33%) | (54,213.07%) | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
3,013.26% | (157.25%) | (215.60%) | (3,937.25%) | (1,674.36%) | (268.55%) | (452.95%) | (5,136.52%) | (415.68%) | (209.22%) |
Average Days of Receivables |
0.00 | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.39 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | — | — | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(0.58) | (0.79) | (9.55) | (1.11) | (261.27) | (730.90) | (1,274.66) | (1,321.33) | (4,218.27) | (8,219.58) |
Cash per Share |
0.08 | 0.68 | 6.51 | 0.31 | 33.15 | 422.22 | 711.96 | 398.67 | 2,479.20 | 4,976.67 |
Shareholders Equity per Share |
0.44 | 0.78 | 4.98 | (0.13) | 15.79 | 422.76 | 714.93 | 43.83 | 1,311.67 | 4,529.33 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.44 | 0.78 | 4.98 | (0.13) | 15.79 | 422.76 | 714.93 | 43.83 | 1,311.67 | 4,529.33 |
Free Cash Flow |
(27.71) | (14.79) | (7.20) | (13.25) | (12.10) | (20.39) | (18.86) | (7.93) | (6.33) | (9.86) |
Working Capital |
(1.30) | 14.28 | 3.27 | 0.56 | 0.19 | 9.27 | 9.01 | 0.18 | 1.96 | 5.41 |
Capital Expenditures |
(0.08) | (0.06) | (0.02) | (1.30) | (0.23) | — | 0.00 | — | — | (0.01) |
Net Current Asset Value |
(1.80) | 14.24 | 3.08 | (1.76) | 0.02 | 9.11 | 8.83 | 0.18 | 1.96 | 5.41 |
| Other line items | ||||||||||
Quick Ratio |
0.70 | 2.37 | 2.17 | 1.02 | 0.50 | 2.95 | 3.79 | 0.90 | 1.81 | 3.67 |
Depreciation/Fixed assets |
1.84 | 11.31 | 0.08 | 1.00 | 4.63 | 0.67 | 0.84 | 5.00 | 0.00 | 0.00 |
Cash ROIC |
(113.76%) | (54.50%) | (90.58%) | (273.85%) | (554.90%) | (86.88%) | (90.02%) | (298.68%) | (111.27%) | (86.36%) |
Accounts Receivable Turnover |
0.00 | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.58) | (0.79) | (9.52) | (1.01) | (256.26) | (730.90) | (1,274.32) | (1,321.33) | (4,218.27) | (8,209.08) |
Capex per Share |
0.00 | 0.00 | (0.03) | (0.11) | (5.01) | 0.00 | (0.34) | 0.00 | 0.00 | (10.50) |
Average Receivables |
0.25 | — | — | — | — | — | — | 0.02 | 0.03 | 0.06 |
Average Payables |
5.35 | 3.69 | 2.82 | 3.11 | 3.03 | 2.74 | 2.12 | 1.88 | 1.61 | 1.33 |
Average Assets |
23.66 | 13.08 | 5.28 | 4.17 | 9.96 | 14.75 | 8.24 | 3.49 | 5.56 | 7.49 |
Average Common Equity |
17.48 | 3.91 | (4.04) | (5.74) | (5.34) | (2.55) | (4.45) | (3.78) | (2.00) | (0.42) |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — | — | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates